SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-07-026003
Filing Date
2007-02-12
Accepted
2007-02-09 21:35:01
Documents
6
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/ AMENDMENT d10qa.htm 10-Q/A 31241
2 EMPLOYMENT ARRANGEMENT EDWARD JACOBS AND INSERT THERAPEUTICS, INC. dex1016.htm EX-10.16 15741
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER SECTION 302 dex311.htm EX-31.1 5240
4 CERTIFICATION OF PRESIDENT & CHIEF FINANCIAL OFFICER SECTION 302 dex312.htm EX-31.2 5279
5 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER SECTION 906 dex321.htm EX-32.1 2647
6 CERTIFICATION OF PRESIDENT & PRINCIPAL FINANCIAL OFFICER SECTION 906 dex322.htm EX-32.2 2710
  Complete submission text file 0001193125-07-026003.txt   64509
Mailing Address 201 SOUTH LAKE AVENUE SUITE 703 PASADENA CA 91101
Business Address 201 SOUTH LAKE AVENUE SUITE 703 PASADENA CA 91101 626-304-3400
ARROWHEAD RESEARCH CORP (Filer) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q/A | Act: 34 | File No.: 000-21898 | Film No.: 07600193
SIC: 8731 Services-Commercial Physical & Biological Research